DEF 14A

Company

Barinthus Biotherapeutics plc.

Filed

March 22, 2024

Period of Report

May 10, 2024

Accession Number

0001828185-24-000017

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →